1. Stoll, Sandra Jasmin, Kroll, Jens. 2012. HOXC9: a key regulator of endothelial cell quiescence and vascular morphogenesis. In Trends in cardiovascular medicine, 22, 7-11. doi:10.1016/j.tcm.2012.06.002. https://pubmed.ncbi.nlm.nih.gov/22841837/
2. Liu, Yunlong, Jing, Liling, Zhang, Jie. 2022. circRNA-mediated upregulation of HOXC9 is correlated with poor outcome and immune microenvironment infiltrates in LUAD. In Biochemical and biophysical research communications, 635, 128-135. doi:10.1016/j.bbrc.2022.10.043. https://pubmed.ncbi.nlm.nih.gov/36272177/
3. Hu, Man, Ou-Yang, Wen, Jing, Doudou, Chen, Rui. . Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer. In Clinical laboratory, 65, . doi:10.7754/Clin.Lab.2019.190122. https://pubmed.ncbi.nlm.nih.gov/31414766/
4. Tang, Yuanxin, Wang, Taifang, Yu, Yue, Yan, Yuhao, Wu, Chunli. 2021. Upregulation of HOXC9 generates interferon-gamma resistance in gastric cancer by inhibiting the DAPK1/RIG1/STAT1 axis. In Cancer science, 112, 3455-3468. doi:10.1111/cas.15043. https://pubmed.ncbi.nlm.nih.gov/34159686/
5. Stoll, Sandra J, Bartsch, Susanne, Augustin, Hellmut G, Kroll, Jens. 2011. The transcription factor HOXC9 regulates endothelial cell quiescence and vascular morphogenesis in zebrafish via inhibition of interleukin 8. In Circulation research, 108, 1367-77. doi:10.1161/CIRCRESAHA.111.244095. https://pubmed.ncbi.nlm.nih.gov/21493894/
6. Wang, Xiangwei, Choi, Jeong-Hyeon, Ding, Jane, Cui, Hongjuan, Ding, Han-Fei. 2013. HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation. In BMC genomics, 14, 830. doi:10.1186/1471-2164-14-830. https://pubmed.ncbi.nlm.nih.gov/24274069/
7. Mao, Ling, Ding, Jane, Zha, Yunhong, Cui, Hongjuan, Ding, Han-Fei. 2011. HOXC9 links cell-cycle exit and neuronal differentiation and is a prognostic marker in neuroblastoma. In Cancer research, 71, 4314-24. doi:10.1158/0008-5472.CAN-11-0051. https://pubmed.ncbi.nlm.nih.gov/21507931/
智鼠故事 
